|
Take heed to this text  |
ReWalk Robotics (Nasdaq:RWLK) introduced that the Facilities for Medicare & Medicaid Companies (CMS) finalized a rule benefitting its exoskeleton expertise.
Earlier this yr, CMS launched a proposal aiming to ascertain new regulatory definition of “brace.” Including the definition of brace would expedite protection and fee for newer expertise and powered units, in response to CMS. This probably allows quicker entry to the newer applied sciences, like these made by ReWalk and Myomo as effectively.
CMS launched the proposal on June 30. ReWalk applauded it because it consists of private exoskeletons within the Medicare profit class for braces. Advantages would lengthen to the ReWalk Private Exoskeleton platform, which permits paralyzed sufferers to face and stroll.
Now, CMS has finalized the Calendar Yr 2024 House Well being Potential Cost System Rule CMS-1780 (“2024 House Well being Rule”) which solidifies the inclusion of exoskeletons within the Medicare brace profit class. The ultimate rule, launched by CMS on Nov. 1, goes into impact on Jan. 1, 2024.
Within the rule, CMS says the exoskeleton adjustments can expedite protection and fee for newer expertise and powered units. Notably, it might assist these with disabilities related to muscular and/or neural situations. The rule finalizes a transparent protection pathway reimbursed by Medicare on a lump-sum foundation.
“Finalization of this rule by CMS is a significant milestone in our efforts to develop entry to this life-changing expertise for the substantial proportion of the spinal twine harm group with Medicare protection,” mentioned Larry Jasinski, CEO of ReWalk Robotics. “The choice by CMS to incorporate private exoskeletons inside an current profit class as a way to expedite Medicare protection and fee is a crucial validation of the constructive impression of exoskeletons, and a message that innovation issues in Medicare coverage choices.”
Editor’s Observe: This text was syndicated from our sister web site MassDevice.
